FGFR2 fusion seen in CCA is most commonly due to chromosomal rearrangement causing a C-terminal substitution of FGFR2 to the region of a binding partner, allowing auto-dimerization of FGFR2 and constitutive activation of downstream signaling pathways [48,49]. Here, FGFR2 is linked to cholangiocarcinoma.